This HTML5 document contains 94 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n13http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n9https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37056536
rdf:type
wikibase:Item
schema:description
article científic artículu científicu espublizáu en 2016 wissenschaftlicher Artikel articolo scientifico наукова стаття, опублікована в травні 2016 مقالة علمية نشرت في 26 مايو 2016 videnskabelig artikel bilimsel makale artigo científico article scientifique wetenschappelijk artikel vedecký článok научни чланак vědecký článek vetenskaplig artikel scientific article published on 26 May 2016
p:P577
wds:Q37056536-345B67F2-6D78-42D5-945A-8553E92D3D90
wdt:P577
2016-05-26T00:00:00Z
p:P2888
wds:Q37056536-73002145-9DED-4C0A-B569-F7525D4EC5BB
wdt:P2888
n9:s40121-016-0110-5
p:P2860
wds:Q37056536-F9249F72-3E6E-4113-BE50-F7CE7BB3E0FB wds:Q37056536-D989B8B7-00B1-42B4-8B92-D91203C63DF3 wds:Q37056536-DC912506-8C99-4D63-9DB5-0CF85638C41A wds:Q37056536-EDF4A3AE-B0E6-4D66-BF51-EFBB1076EED7 wds:Q37056536-C4694AEF-6108-4898-90E5-BB1901E8F9BA wds:Q37056536-A3D00461-38C9-447B-A1F1-C35C832300F6 wds:Q37056536-AFB87FDA-2061-4D3E-8988-EA13725E5B2C wds:Q37056536-A193688B-ACBA-485E-9C89-832CD54C5E46 wds:Q37056536-720513A9-9010-45AA-A25E-DD1281921780 wds:Q37056536-3DC2EBF6-A1F0-485F-A52E-C13E317E099D wds:Q37056536-5B8B7CBA-A0E5-4E0B-AF60-35768A553204 wds:Q37056536-5C94C884-49FC-4844-B63C-F3A23BEE5BA0 wds:Q37056536-1E80F04D-E409-40E9-9B26-0FAC5166B0EF wds:Q37056536-30F965C1-48E3-4FDD-8958-C1A86DF74D36 wds:Q37056536-1683F31E-C422-41B4-8BA4-98B272FBFA25
wdt:P2860
wd:Q42202756 wd:Q39009632 wd:Q41563622 wd:Q29620620 wd:Q29620612 wd:Q29620617 wd:Q29620318 wd:Q45350638 wd:Q37966627 wd:Q58324800 wd:Q42220608 wd:Q34452419 wd:Q42211652 wd:Q42211649 wd:Q42226688
p:P2093
wds:Q37056536-CE19B1C4-8019-4F0E-A285-C2E291C2440A wds:Q37056536-CE7A9379-5974-4F85-8AA5-000B87D50F2D wds:Q37056536-7DC0FAD4-9D32-459B-851A-4312AB1A3734 wds:Q37056536-65D777F2-75BC-4678-AF6F-8490D4D1228A
wdt:P2093
Florin A Caruntu Peter Ferenci Gabriella Lengyel Diethelm Messinger
rdfs:label
Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial.
skos:prefLabel
Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial. Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial
schema:name
Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial. Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial
p:P50
wds:Q37056536-AB47BA04-6727-47DF-9291-145E4792A893 wds:Q37056536-1728F9A7-8D9D-4318-ACF9-B4C3382DF1DD
wdt:P50
wd:Q56980311 wd:Q56544163
p:P1476
wds:Q37056536-0080F184-D3F7-4639-AB46-1CCAC0C227D9
wdt:P1476
Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial
p:P304
wds:Q37056536-8B3AA4E0-14A5-4377-92B5-5471B035ACA4
wdt:P304
113-124
p:P31
wds:Q37056536-BF059CDF-29FF-47E3-BA1F-41A574193077
wdt:P31
wd:Q13442814
p:P921
wds:Q37056536-976ED501-A8F9-4C83-AF77-9B8672166DDC
wdt:P921
wd:Q708693
p:P698
wds:Q37056536-1E5071BF-F4BB-463E-A66B-95639C5232EF
wdtn:P698
n12:27228998
wdt:P698
27228998
p:P1433
wds:Q37056536-0DED3B9C-50F6-4981-86ED-9458C9A14DC7
wdt:P1433
wd:Q26842457
p:P433
wds:Q37056536-809FEF2B-CAD2-4B5C-B20C-52110FB19C33
p:P478
wds:Q37056536-31B22120-C987-45B2-BD11-0718B8BECF46
wdt:P433
2
wdt:P478
5
p:P356
wds:Q37056536-F1F469AB-33BC-4361-A150-14CAF46EDB6C
wdtn:P356
n13:S40121-016-0110-5
wdt:P356
10.1007/S40121-016-0110-5
p:P932
wds:Q37056536-B2FD6904-58BE-47B4-9061-FAE86A48C118
wdt:P932
4929089